Cargando…

Folic Acid and Vitamin B12 Prevent Deleterious Effects of Rotenone on Object Novelty Recognition Memory and Kynu Expression in an Animal Model of Parkinson’s Disease

Parkinson’s disease (PD) is characterized by a range of motor signs, but cognitive dysfunction is also observed. Supplementation with folic acid and vitamin B12 is expected to prevent cognitive impairment. To test this in PD, we promoted a lesion within the substantia nigra pars compacta of rats usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kretzschmar, Gabriela Canalli, Targa, Adriano D. S., Soares-Lima, Sheila Coelho, dos Santos, Priscila Ianzen, Rodrigues, Lais S., Macedo, Daniel A., Ribeiro Pinto, Luis Felipe, Lima, Marcelo M. S., Boldt, Angelica Beate Winter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778036/ https://www.ncbi.nlm.nih.gov/pubmed/36553663 http://dx.doi.org/10.3390/genes13122397

Ejemplares similares

Olfactory impairment is related to REM sleep deprivation in rotenone model of Parkinson's disease
por: Aurich, Mariana F., et al.
Publicado: (2017)

Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation
por: Rodrigues, Lais S., et al.
Publicado: (2014)

Discovering KYNU as a feature gene in hidradenitis suppurativa
por: Liang, Chen, et al.
Publicado: (2023)

Glucocorticoid Receptor Gene (NR3C1) Polymorphisms and Metabolic Syndrome: Insights from the Mennonite Population
por: Kolb, Kathleen Liedtke, et al.
Publicado: (2023)

Absence of a synergic nigral proapoptotic effect triggered by REM sleep deprivation in the rotenone model of Parkinson´s disease
por: Kmita, Luana C, et al.
Publicado: (2019)

Inflammation-Induced Mucosal KYNU Expression Identifies Human Ileal Crohn’s Disease
por: Huhn, Meik, et al.
Publicado: (2020)

KYNU-related transcriptome profile and clinical outcome from 2994 breast tumors
por: Li, Yiliang, et al.
Publicado: (2023)

Chronic sleep restriction in the rotenone Parkinson’s disease model in rats reveals peripheral early-phase biomarkers
por: Fagotti, Juliane, et al.
Publicado: (2019)

KYNU, a novel potential target that underpins CD44‐promoted breast tumour cell invasion
por: Al‐Mansoob, Maryam, et al.
Publicado: (2021)

KYNU as a Biomarker of Tumor-Associated Macrophages and Correlates with Immunosuppressive Microenvironment and Poor Prognosis in Gastric Cancer
por: Shen, Kaiyu, et al.
Publicado: (2023)

GWAS-Top Polymorphisms Associated With Late-Onset Alzheimer Disease in Brazil: Pointing Out Possible New Culprits Among Non-Coding RNAs
por: Kretzschmar, Gabriela Canalli, et al.
Publicado: (2021)

Differential Gene Expression and Methylation Analysis of Melanoma in TCGA Database to Further Study the Expression Pattern of KYNU in Melanoma
por: Wang, Min, et al.
Publicado: (2022)

Neutrophil Extracellular Traps: A Perspective of Neuroinflammation and Complement Activation in Alzheimer’s Disease
por: Kretzschmar, Gabriela Canalli, et al.
Publicado: (2021)

The Second Highest Prevalence of Celiac Disease Worldwide: Genetic and Metabolic Insights in Southern Brazilian Mennonites
por: Oliveira, Luana Caroline, et al.
Publicado: (2023)

Complement receptor 1 (CR1, CD35) association with susceptibility to leprosy
por: Kretzschmar, Gabriela Canalli, et al.
Publicado: (2018)

MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19
por: Bumiller-Bini, Valéria, et al.
Publicado: (2021)

Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of “Fogo Selvagem” Pemphigus Foliaceus
por: Oliveira, Luana Caroline, et al.
Publicado: (2019)

The Experience of Novelty and the Novelty of Experience
por: Skavronskaya, Liubov, et al.
Publicado: (2020)

REM sleep deprivation promotes a dopaminergic influence in the striatal MT2 anxiolytic-like effects
por: Noseda, Ana Carolina D., et al.
Publicado: (2016)

A circuitry for sleep in Parkinson's disease
por: Targa, Adriano D.S., et al.
Publicado: (2016)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

A Homozygous Deletion of Exon 5 of KYNU Resulting from a Maternal Chromosome 2 Isodisomy (UPD2) Causes Catel-Manzke-Syndrome/VCRL Syndrome
por: Schüle, Isabel, et al.
Publicado: (2021)

Novelty‐like activation of locus coeruleus protects against deleterious human pretangle tau effects while stress‐inducing activation worsens its effects
por: Omoluabi, Tamunotonye, et al.
Publicado: (2021)

Presence of insoluble Tau following rotenone exposure ameliorates basic pathways associated with neurodegeneration
por: Chaves, Rodrigo S., et al.
Publicado: (2016)

Novelty or Surprise?
por: Barto, Andrew, et al.
Publicado: (2013)

Therapeutical Novelties
Publicado: (1854)

Persistent deleterious effects of a deleterious Wolbachia infection
por: Ross, Perran A., et al.
Publicado: (2020)

Biophysical Characterization of α-Synuclein and Rotenone Interaction
por: Silva, Blanca A., et al.
Publicado: (2013)

Hormetic effect of rotenone in primary human fibroblasts
por: Marthandan, Shiva, et al.
Publicado: (2015)

Breast-feeding and deleterious oral habits in mouth and nose breathers
por: Voi Trawitzki, Luciana Vitaliano, et al.
Publicado: (2015)

Taxonomic novelties in this issue
Publicado: (2011)

Taxonomic novelties in Scapania
por: Váňa, Jiří, et al.
Publicado: (2012)

Taxonomic novelties in this issue
Publicado: (2011)

Taxonomic novelties in this issue
Publicado: (2012)

Novelty, Information and Surprise
por: Palm, Günther
Publicado: (2012)

Taxonomic novelties in this issue
Publicado: (2012)

Taxonomic novelties in this issue
Publicado: (2014)

Taxonomic novelties in this issue
Publicado: (2013)

Taxonomic novelties in this issue
Publicado: (2015)

Taxonomic novelties in this issue
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oh8kqlbuuq09gcjkq3rfnbcjvc